STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION - Narrative (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Shares of newly vested common stock surrendered to the company to satisfy tax withholding obligations (in shares) | 61,868 | |
| Shares of newly vested common stock surrendered to the Company to satisfy tax withholding obligations | $ 5,400 | $ 9,000 |
| Warrants to purchase common stock (in shares) | 21,548,936 | |
| Exercise price of warrants (in dollars per share) | $ 0.46 | |
| Stock based compensation | $ 300,000 | $ 500,000 |
| Restricted Stock Units (RSUs) | ||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Vested (in shares) | (2,063,790) | |
| Amended and Restated 2018 Stock Award and Incentive Plan | ||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Expiration term (in years) | 5 years | |
| Weighted average remaining life (in months) | 6 months | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|